Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0000950170-24-025191

EVP, CFO & Treasurer sold 33,849 shares at an average $1.18 ($39,788)

From the SEC's structured data for this filing

Trades in this filing

Mason Michael · EVP, CFO & Treasurer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-29 Sale : show line 1 in the form −27,687 $1.17 $32,394 404,918 D
2024-03-01 Sale : show line 2 in the form −6,162 $1.20 $7,394 398,756 D
Open-market sales · 33,849 sh · avg $1.18 · $39,788
Loading xslF345X05/ownership.xml…